Toosendanin Induces Hepatotoxicity by Facilitating ALOX5-Mediated Lipid Peroxidation and Sensitizing Cells to

Jiajie Ni1, Liru Huang1, Yifan Tian1

  • 1School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.

Insights

Toosendanin, a component of traditional Chinese medicine, causes liver damage by triggering ferroptosis, a cell death pathway. This process involves 5-lipoxygenase (ALOX5), highlighting a new mechanism for hepatotoxicity.

Area of Science:

  • Biochemistry
  • Toxicology
  • Pharmacology

Background:

  • Fructus Meliae Toosendan (FMT) is a traditional Chinese medicine used for ascariasis.
  • Hepatotoxicity is a limiting factor in FMT application.
  • Toosendanin (TSN) is identified as the primary toxic component responsible for FMT-induced liver injury, but its mechanism is unclear.

Purpose of the Study:

  • To elucidate the mechanism of TSN-induced hepatotoxicity.
  • To investigate the role of ferroptosis in TSN-induced liver injury.
  • To identify key molecular targets involved in TSN toxicity.

Main Methods:

  • In vitro studies using HepG2 cells treated with TSN.
  • In vivo studies using Balb/c and C57BL/6 mice.
  • Analysis of gene transcription, protein expression, lipid peroxidation, and ferroptosis markers.
  • Network pharmacology and oxidative lipidomics approaches.

Main Results:

  • TSN exposure induced ferroptosis in hepatocytes and mouse livers.
  • Elevated 5-lipoxygenase (ALOX5) expression and its metabolites were observed.
  • ALOX5 levels correlated with hepatocyte sensitivity to TSN-induced damage.
  • ALOX5 knockdown significantly reduced TSN-induced liver injury and ferroptosis.

Conclusions:

  • TSN induces hepatotoxicity by promoting ALOX5-mediated lipid peroxidation.
  • This process sensitizes hepatocytes to ferroptosis, leading to liver damage.
  • Targeting ALOX5 may offer a therapeutic strategy for TSN-induced hepatotoxicity.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.8K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.2K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K